ArticleBioengineering (Basel, Switzerland)2024
Brain Tumor Detection and Categorization with Segmentation of Improved Unsupervised Clustering Approach and Machine Learning Classifier.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- A Multilevel Deep Learning Model for Automated Brain Tumor Segmentation Using Magnetic Resonance Images.Diagnostics (Basel, Switzerland) · 2026Article
- An Optimized Strategy for Brain Tumor Classification Using SO(3) Equivariant Graph Neural Networks with Snow Geese Algorithm in MRI Imaging.Journal of molecular neuroscience : MN · 2026Article
- Article
- Deep convolutional GAN and hypernet-based neural architecture search for brain tumor diagnosis detection and classification.PloS one · 2026Article
- XcepFusion for brain tumor detection using a hybrid transfer learning framework with layer pruning and freezing.Scientific reports · 2025Article
- An intelligent brain tumor detection model using lightweight hybrid twin attentive pyramid convolutional network.Scientific reports · 2025Article
- Accurate and real-time brain tumour detection and classification using optimized YOLOv5 architecture.Scientific reports · 2025Article
- Artificial Intelligence in Public Health: Bridging Today's Trends with Tomorrow's Possibilities.Bioengineering (Basel, Switzerland) · 2025Article
- Advanced Deep Learning and Machine Learning Techniques for MRI Brain Tumor Analysis: A Review.Sensors (Basel, Switzerland) · 2025Review
- CMNet: an asymmetric dual-branch network for accurate cotton segmentation.Frontiers in plant science · 2025Article
- SMCFO: a novel cuttlefish optimization algorithm enhanced by simplex method for data clustering.Frontiers in artificial intelligence · 2025Article
- Brain tumor classification utilizing pixel distribution and spatial dependencies higher-order statistical measurements through explainable ML models.Scientific reports · 2024Article
- An Unsupervised Error Detection Methodology for Detecting Mislabels in Healthcare Analytics.Bioengineering (Basel, Switzerland) · 2024Article
- Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics.Clinical proteomics · 2024Article
- Enhancing brain tumor detection in MRI with a rotation invariant Vision Transformer.Frontiers in neuroinformatics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is no doubt that brain tumors are one of the leading causes of death in the world. A biopsy is considered the most important procedure in cancer diagnosis, but it comes with drawbacks, including low sensitivity, risks during biopsy treatment, and a lengthy wait for results. Early identification provides patients with a better prognosis and reduces treatment costs. The conventional methods of identifying brain tumors are based on medical professional skills, so there is a possibility of human error. The labor-intensive nature of traditional approaches makes healthcare resources expensive. A variety of imaging methods are available to detect brain tumors, including magnetic resonance imaging (MRI) and computed tomography (CT). Medical imaging research is being advanced by computer-aided diagnostic processes that enable visualization. Using clustering, automatic tumor segmentation leads to accurate tumor detection that reduces risk and helps with effective treatment. This study proposed a better Fuzzy C-Means segmentation algorithm for MRI images. To reduce complexity, the most relevant shape, texture, and color features are selected. The improved Extreme Learning machine classifies the tumors with 98.56% accuracy, 99.14% precision, and 99.25% recall. The proposed classifier consistently demonstrates higher accuracy across all tumor classes compared to existing models. Specifically, the proposed model exhibits accuracy improvements ranging from 1.21% to 6.23% when compared to other models. This consistent enhancement in accuracy emphasizes the robust performance of the proposed classifier, suggesting its potential for more accurate and reliable brain tumor classification. The improved algorithm achieved accuracy, precision, and recall rates of 98.47%, 98.59%, and 98.74% on the Fig share dataset and 99.42%, 99.75%, and 99.28% on the Kaggle dataset, respectively, which surpasses competing algorithms, particularly in detecting glioma grades. The proposed algorithm shows an improvement in accuracy, of approximately 5.39%, in the Fig share dataset and of 6.22% in the Kaggle dataset when compared to existing models. Despite challenges, including artifacts and computational complexity, the study's commitment to refining the technique and addressing limitations positions the improved FCM model as a noteworthy advancement in the realm of precise and efficient brain tumor identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.